StockData
Sagimet Biosciences Inc. logo

Sagimet Biosciences Inc. (SGMT) stock

SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$9.85−0.28 (-2.76%)

Close on Nov 17, 2026Market cap $612.26MP/E –Yield –

Sagimet Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Sagimet Biosciences's profit margin for the twelve months ending Dec 31, 2023 was -1393.8%. For fiscal 2023 it was -1393.8%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-1393.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2023Sep 30, 2023-317.6%–

More Sagimet Biosciences figures

See a number that looks wrong?